Tissue Repository: CTCL Collection Protocol
NCT02840747 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2025-11-04
Summary
This document is a protocol for a non-interventional human research study in which the investigator hopes to better understand the changes that take place in T cells in Cutaneous T-cell lymphoma (CTCL). The purpose of this study is to establish a protocol for the collection and storage of tissue samples from patients with CTCL for future research studies. Collection and storage of tissue samples from control patients will also be carried out.
Conditions
- Lymphoma, T-Cell, Cutaneous
- Lymphomatoid Papulosis
- Sézary Syndrome
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Larisa J. Geskin, MD · Columbia University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-07-31
- Primary Completion
- 2026-10-31
- Completion
- 2026-10-31
Countries
- United States
Study Locations
More Related Trials
-
Combined Rituximab and Lenalidomide Treatment for Untreated Patients With Follicular Lymphoma
NCT01476787 ·Status: COMPLETED ·Phase: PHASE3
-
Procurement of Follicular B Cell Lymphoma Cells for the Purpose of Possible Use in Future Clinical Trials
NCT00487513 ·Status: COMPLETED
-
S8809-S9800-S9911-S9704-A Study of Blood and Tissue Samples From Patients With Follicular Lymphoma Treated With Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone
NCT00933127 ·Status: COMPLETED
-
Cellular Immunotherapy for Relapsed or Refractory Lymphoma Data Collection
NCT06541327 ·Status: RECRUITING
-
Study Of Intratumoral G100 In Cutaneous T Cell Lymphoma
NCT03742804 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study of MT-101 in Subjects With CD5+ Relapsed/Refractory TCL
NCT05138458 ·Status: SUSPENDED ·Phase: PHASE1/PHASE2
-
Long-term Use of Romidepsin in Patients With CTCL
NCT02296398 ·Status: COMPLETED
-
Ritlecitinib in CTCL
NCT05879458 ·Status: TERMINATED ·Phase: PHASE2
-
Immunochemotherapy, Zevalin, and Bone Marrow Transplant for Follicular Lymphoma
NCT01130194 ·Status: COMPLETED ·Phase: PHASE2
-
CELTIC-1: A Phase 2B Study of Cerdulatinib in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL)
NCT04021082 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Lenalidomide Plus Rituxan for Untreated Mantle Cell Lymphoma
NCT01472562 ·Status: COMPLETED ·Phase: PHASE2
-
CHO(E)P-14 Followed by Alemtuzumab Consolidation in Peripheral T Cell Lymphoma
NCT01806337 ·Status: COMPLETED ·Phase: PHASE2
-
Irradiated Donor Lymphocytes and Rituximab in Treating Patients With Relapsed or Refractory Lymphoproliferative Disease
NCT00176475 ·Status: TERMINATED ·Phase: PHASE1
-
Poly ICLC, Radiation, and Romidepsin for Advanced Cutaneous T Cell Lymphoma
NCT02061449 ·Status: TERMINATED ·Phase: PHASE1
-
Immunostimulatory CpG SD-101 + RT in Recurrent/Progressive Lymphoma After Allogeneic Hematopoietic Cell Transplantation (HCT)
NCT01745354 ·Status: TERMINATED ·Phase: PHASE1
-
Observational Study for the Cytofluorimetric Analysis of Cerebrospinal Fluid in Non-Hodgkin's Lymphoma Patients
NCT00949741 ·Status: COMPLETED
-
A Study of Molecular Subtyping-based Therapeutic Strategies for Cutaneous T-cell Lymphoma
NCT06436677 ·Status: RECRUITING
-
Rituximab in Treating Patients With Follicular Non-Hodgkin's Lymphoma
NCT00227695 ·Status: COMPLETED ·Phase: PHASE3
-
Chronic and Late Effects of Non-Hodgkin's Lymphoma and Its Treatment in Long Term Survivors
NCT00001301 ·Status: COMPLETED
-
Novel Combinations of CC-122, CC-223, CC-292, and Rituximab in Diffuse Large B-cell Lymphoma and Follicular Lymphoma
NCT02031419 ·Status: TERMINATED ·Phase: PHASE1
-
Evaluate Rituximab in Obtaining PCR (Polymerase Chain Reaction) Negative Leukapheresis Product in Patients With Relapsed Follicular Lymphoma
NCT00856245 ·Status: COMPLETED ·Phase: PHASE2
-
Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma
NCT06588868 ·Status: RECRUITING
-
Minimal Residual Disease in Peripheral T-cell Lymphoma
NCT03297697 ·Status: COMPLETED
-
Phase Ⅰ Clinical Study of Anti-CD52 Monoclonal Antibody in NHL and T-PLL
NCT05557903 ·Status: UNKNOWN ·Phase: PHASE1
-
TreAtments and outComes in paTients With prImary CutAneous Lymphoma
NCT05518851 ·Status: RECRUITING